Kamada logo

Kamada Share Price (NASDAQ: KMDA)

$6.91

-0.11

(-1.57%)

Last updated on

Check the interactive Kamada Stock chart to analyse performance

Kamada stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$6.91
    Today's High:$7.02

    Day's Volatility :1.57%

  • 52 Weeks Low:$5.17
    52 Weeks High:$9.16

    52 Weeks Volatility :43.53%

Kamada Stock Returns

PeriodKamada LtdSector (Health Care)Index (Russel 2000)
3 Months
0.87%
3.6%
0.0%
6 Months
2.5%
-7.7%
0.0%
1 Year
27.71%
-12.6%
0.0%
3 Years
41.75%
9.5%
-4.7%

Kamada Ltd Key Stats

Check Kamada key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$7.02
Open
$7.02
Today's High
$7.02
Today's Low
$6.91
Market Capitalization
$399.9M
Today's Volume
$24.6K
52 Week High
$9.155
52 Week Low
$5.17
Revenue TTM
$169.5M
EBITDA
$38.4M
Earnings Per Share (EPS)
$0.32
PE Ratio
21.63
Dividend Yield
3.0%
Profit Margin
11.22%
Quarterly Earnings Growth YOY
0.63%
Return On Equity TTM
7.44%

Stock Returns calculator for Kamada Stock including INR - Dollar returns

The Kamada stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Kamada investment value today

Current value as on today

₹1,25,458

Returns

₹25,458

(+25.46%)

Returns from Kamada Stock

₹20,174 (+20.17%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Kamada Stock

-43%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Kamada Stock from India on INDmoney has decreased by -43% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Kamada Ltd

  • Name

    Holdings %

Analyst Recommendation on Kamada Stock

Rating
Trend

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Kamada(by analysts ranked 0 to 5 stars)

Kamada Share Price Target

What analysts predicted

Upside of 102.6%

Target:

$14.00

Current:

$6.91

Kamada share price target is $14.00, a slight Upside of 102.6% compared to current price of $6.91 as per analysts' prediction.

Kamada Stock Insights

  • Price Movement

    In the last 1 month, KMDA stock has moved down by -7.4%
  • Increasing Revenue

    Revenue is up for the last 3 quarters, 39.00M → 44.75M (in $), with an average increase of 6.5% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, 3.80M → 7.37M (in $), with an average increase of 25.1% per quarter

Kamada Ltd Financials

Revenue
Profit
Cash Flow
Annually
Quarterly
FY19
FY20
FY21
FY22
FY23
FY24
FY24Y/Y Change
Revenue
$161.0M
↑ 12.93%
Net Income
$14.5M
↑ 74.58%
Net Profit Margin
8.99%
↑ 3.18%

Kamada Technicals Summary

Sell

Neutral

Buy

Kamada is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Kamada Ltd Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Kamada Ltd logo
-3.6%
2.5%
27.71%
41.75%
-25.48%
Haleon Plc Spon Ads logo
1.5%
-7.33%
-3.49%
69.05%
32.32%
United Therapeutics Corporation logo
3.57%
-1.69%
-13.51%
34.83%
71.41%
Zoetis Inc. logo
6.13%
-8.28%
-14.8%
-1.88%
-3.48%
Neurocrine Biosciences Inc. logo
8.29%
21.94%
11.59%
32.16%
20.59%

About Kamada Ltd

Kamada Ltd. manufactures and sells plasma-derived protein therapeutics. Its products include KAMRAB/KEDRAB indicated as prophylaxis of rabies; CYTOGAM for prophylaxis of Cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplants; VARIZIG for post exposure prophylaxis of varicella; WINRHO SDF for immune thrombocytopenic purpura and suppression of rhesus isoimmunization; HEPAGAM B for prevention of hepatitis B recurrence liver transplants and post-exposure prophylaxis; GLASSIA for intravenous AATD; KAMRHO (D) IM for prophylaxis of hemolytic disease of newborns; and Echis coloratus and Vipera palaestinae Antiserum to treat snake bite. The company also distributes biopharmaceutical products in Israel, including BRAMITOB to manage chronic pulmonary infection; FOSTER to treat asthma; TRIMBOW for chronic obstructive pulmonary disease; PROVOCHOLINE for the diagnosis of bronchial airway hyperactivity; AEROBIKA, an OPEP device; RUPAFIN and RUPAFIN ORAL SOLUTION for allergic rhinitis and Urticaria; SINTREDIUS for rheumatoid arthritis, systemic lupus erythematosus, and mild-moderate juvenile dermatomyositis; IVIG for various immunodeficiency-related conditions; VARITECT for chicken pox and zoster herpes; ZUTECTRA and HEPATECT CP for prevention of hepatitis B; MEGALOTECT CP for CMV virus; RUCONEST for angioedema attack; HEPARIN SODIUM INJECTION for thrombo-embolic disorders and prophylaxis of deep vein thrombosis and thromboembolic events; ALBUMIN and ALBUMIN for blood plasma; Factor VIII for hemophilia type A; and Factor IX for hemophilia type B. In addition, it distributes COAGADEX to treat hereditary factor X deficiency; IXIARO for Japanese encephalitis; VIVOTIF for salmonella typhi; PROCYSBI for nephropathic cystinosis; LAMZEDE for alpha-mannosidosis; RYPLAZIM for hypoplasminogenemia; ELIGARD for prostate cancer; and BEVACIZUMAB KAMADA for various cancers. The company was incorporated in 1990 and is headquartered in Rehovot, Israel.
Organization
Kamada
Employees
420
CEO
Mr. Amir London
Industry
Health Technology

Key Management of Kamada Ltd

NameTitle
Mr. Amir London
Chief Executive Officer
Mr. Chaime Orlev
Chief Financial Officer
Mr. Eran Nir
Chief Operating Officer
Mr. Jon R. Knight
Vice President of US Commercial Operations
Mr. Boris Gorelik
Vice President of Business Development & Strategic Programs
Mr. David Tsur
Co-Founder & Independent Deputy Chairman of the Board
Mr. Nir Livneh B.A., L.L.B.
VP, General Counsel & Corporate Secretary
Ms. Hanni Neheman
Vice President of Marketing & Sales
Ms. Liron Reshef
Vice President of Human Resources
Ms. Shavit Beladev
Vice President of Kamada Plasma

Important FAQs about investing in KMDA Stock from India :

What is Kamada share price today?

Kamada share price today is $6.91 as on at the close of the market. Kamada share today touched a day high of $7.02 and a low of $6.91.

What is the 52 week high and 52 week low for Kamada share?

Kamada share touched a 52 week high of $9.16 and a 52 week low of $5.17. Kamada stock price today i.e. is closed at $6.91, lower by 24.52% versus the 52 week high.

How to invest in Kamada Stock (KMDA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Kamada on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Kamada Shares that will get you 0.2171 shares as per Kamada share price of $6.91 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Kamada Stock (KMDA) from India?

Indian investors can start investing in Kamada (KMDA) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Kamada stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Kamada share’s latest price of $6.91 as on August 30, 2025 at 1:29 am IST, you will get 1.4472 shares of Kamada. Learn more about fractional shares .

What are the returns that Kamada has given to Indian investors in the last 5 years?

Kamada stock has given -25.48% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?